Multiple ganciclovir-resistant strains in a newborn with symptomatic congenital human cytomegalovirus infection

被引:16
|
作者
Campanini, Giulia [1 ]
Zavattoni, Maurizio [1 ]
Cristina, Emilio [2 ]
Gazzolo, Diego [3 ]
Stronati, Mauro [4 ]
Baldanti, Fausto [1 ]
机构
[1] Fdn IRCCS Policlin San Matteo, Virol & Microbiol Dept, Mol Virol Unit, I-27100 Pavia, Italy
[2] IRCCS Ist Giannina Gaslini, Infect Dis Unit, Genoa, Italy
[3] C Arrigo Childrens Hosp, Dept Maternal Fetal & Neonatal Med, Alessandria, Italy
[4] Fdn IRCCS Policlin San Matteo, Neonatol & Neonatal Intens Care Unit, Pavia, Italy
关键词
Ganciclovir; Resistance; Congenital; HCMV mutations; UL97; GENE; MUTATIONS; EMERGENCE; THERAPY;
D O I
10.1016/j.jcv.2012.01.020
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A case of human cytomegalovirus (HCMV) drug-resistance in a congenitally infected newborn is described. Unusual aspects of this case include: (i) the detection of an extremely complex virus population, composed of a mixture of wild-type (wt) and multiple mutant ganciclovir (GCV) and valganciclovir (val-GCV) resistant strains carrying a variety of known mutations in UL97; (ii) the identification of novel UL97 mutations and (iii) the first time detection of combined UL97 drug resistance mutations in the same viral strain. In detail, four known UL97 single-nucleotide mutations (A594T/V, M460V/I, C592G), a new amino-acid substitution (C607S), and a new deletion (597-600) in one of the three UL97 hot spots for GCV/val-GCV resistance (codons 460, 520 and 590-607) were detected. In addition, the combination of M460V + A594V and M460V + C592G was observed for the first time. The emergence of HCMV drug-resistance in symptomatic congenital infections chronically treated with GCV or val-GCV should be taken into account. The immaturity of the neonatal immune system may contribute to selection of complex virus populations in these patients. (C) 2012 Elsevier B. V. All rights reserved.
引用
收藏
页码:86 / 88
页数:3
相关论文
共 50 条
  • [1] Treatment of ganciclovir-resistant human cytomegalovirus infection
    Grossi, P
    Baldanti, F
    JOURNAL OF NEPHROLOGY, 1997, 10 (03) : 146 - 151
  • [2] Ganciclovir-resistant cytomegalovirus infection in renal transplantation
    Vaz, Raquel
    Barros, Francisca
    Tavares, Isabel
    Bustorff, Manuela
    Ferreira, Ines
    Pestana, Manuel
    CLINICAL KIDNEY JOURNAL, 2014, 7 (02): : 210 - 213
  • [3] Cutaneous ulcers in ganciclovir-resistant cytomegalovirus infection
    Wang, C.
    Mar, A.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 121 - 121
  • [4] Ganciclovir-resistant cytomegalovirus
    Legendre, C
    LANCET, 2000, 356 (9238): : 1356 - 1356
  • [5] Update in management of ganciclovir-resistant cytomegalovirus infection
    Avery, Robin K.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (04) : 433 - 437
  • [6] GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS
    EBRIGHT, JR
    CRANE, LR
    AIDS, 1991, 5 (05) : 604 - 604
  • [7] Ganciclovir-resistant cytomegalovirus
    Swierkosz, EM
    LABORATORY MEDICINE, 1997, 28 (11) : 698 - 698
  • [8] GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS INFECTION IN A RENAL TRANSPLANT RECIPIENT
    Stangenberg, S.
    John, G.
    Ratanjee, S.
    Fassett, R.
    Kark, A.
    D'Intini, V.
    Ranganathan, D.
    Healy, H.
    NEPHROLOGY, 2010, 15 : 63 - 63
  • [9] Development of Maribavir-Resistant Cytomegalovirus Infection Following Treatment of Ganciclovir-Resistant Cytomegalovirus Infection
    Hutchins, A.
    Pasley, T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S462 - S463
  • [10] Genetic analysis of a ganciclovir-resistant human cytomegalovirus mutant
    Khan, RF
    Mori, S
    Eizuru, Y
    Ishii, KK
    Minamishima, Y
    ANTIVIRAL RESEARCH, 1998, 40 (1-2) : 95 - 103